I

Illumina

ILMN

122.370
USD
-0.25
(-0.20%)
قبل الجلسة
حجم التداول
1
الربح لكل سهم
0
العائد الربحي
0
P/E
-8
حجم السوق
23,143,104,000
الأفكار والتحليلات
هشام منسي
منذ شهرين
buy
I
ILMN
2024-07-24 10:43
أصول ذات صلة
ABBV
4.380
(2.36%)
189.700 USD
AMGN
2.78
(0.84%)
335.22 USD
BMY
0.620
(1.30%)
48.180 USD
DHR
3.66
(1.32%)
280.75 USD
GSK
0.865
(2.23%)
39.650 USD
PFE
0.115
(0.38%)
30.650 USD
SPGI
6.01
(1.24%)
490.40 USD
T
TDOC
-0.85000
(-9.00%)
8.59000 USD
TMO
9.03
(1.47%)
621.78 USD
الأخبار المقالات

العنوان: Illumina

القطاع: Healthcare
الصناعة: Diagnostics & Research
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.